Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2026-01-17 @ 11:10 PM
Study NCT ID:
NCT00129805
Status:
COMPLETED
Last Update Posted:
2008-08-19
First Post:
2005-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)
Sponsor:
Tanabe Pharma Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MCI9042-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
General Manager, Clinical Research Department I
Old Organization:
Mitsubishi Tanabe Pharma Corporation